Veracyte Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Veracyte Inc 's inventory turnover ratio sequentially decreased to 4.84 in the second quarter 2026, unsurprisingly, as the Veracyte Inc markets continue to deteriorate, and VCYT's faces growing challenges to bring down its inventories. Veracyte Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 75 days, from 60 days, in the Mar 31 2026 quarter.

Within Healthcare sector 76 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 631, from total ranking in the first quarter 2026 at 769.

VCYT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Veracyte Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VCYT Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	-9.45 %	-11.7 %	-5.54 %	-0.18 %	29.92 %
Y / Y Cost of Sales Growth	-91.43 %	17.86 %	6.18 %	13.79 %	18.52 %
Inventory Turnover Ratio (TTM)	4.84	6.05	5.64	5.47	5.3
VCYT's Total Ranking	# 631	# 769	# 741	# 752	# 725
Average inventory processing period	75	60	65	67	69
Seq. Inventory Growth	5.79 %	4.23 %	1.08 %	-18.76 %	3.16 %
Seq. Cost of Sales Growth	-91.69 %	-2.94 %	3.03 %	3.13 %	14.29 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 6
Healthcare Sector	# 77
Overall Market	# 631

Inventory Turnover Ratio Statistics
High	Average	Low
19.97	7.07	3.97
(Mar 31 2014)		(Jun 30 2020)

VCYT Company Profile >> Back to VCYT Efficiency Comparisons >> Compare VCYT Inventory Turnover Ratio to its Competitors

Financial Statements
Veracyte Inc 's Inventories	$ 23 Millions	Visit VCYT's Balance sheet
Veracyte Inc 's Cost of Revenues TTM	$ 103 Millions	Visit VCYT's Income Statement
What are VCYT's Sales?		Visit VCYT's Sales by Segment

Other Inventory Turnover Ratios
Veracyte Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VCYT's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VCYT's Competitors
Inventory Turnover Ratio for VCYT's Suppliers
Inventory Turnover Ratio for VCYT's Customers

You may also want to know
VCYT's Sales Growth Rates	VCYT's Pe Price to earnings ratio	VCYT's Receivables Turnover Ratio	VCYT's Stock Quote
VCYT's Net Income Growth Rates	VCYT's Ps Price to Sales ratio	VCYT's Sales per Employee	VCYT's Asset Turnover Ratio
VCYT's Net Margin	VCYT's Pb Price to Book ratio	VCYT's Financial Strength Ratios	VCYT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Adm Tronics Unlimited Inc	6.05	$ 1.970 Millions	$ 0 Millions
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions

Date modified: 2026-09-02T19:45:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.